Consistent with this hypothesis, introduction of a constitutively active form of the Mpl receptor into bone marrow cells cooperates with Rbm15-Mkl1 and leads to myeloproliferative disease with a high frequency. The gene discussed is RBM15; the disease is myeloproliferative disorder.